ONR-001

N/A

Report date: 2025/01/26 16:39:15
NME

Base Information

Drug NameONR-001
Drug Alias NameTET2 activator (ONIRIA Therapeutics)ONR-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMethylcytosine dioxygenase TET2 stimulants
TargetsMethylcytosine dioxygenase TET2
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOniria Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesOniria Therapeutics SL
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A